This announcement is a separate document:
先健科技：自願公告 - IBS可吸收藥物洗脫冠脈支架系統中國確證性臨床首例成功入組
LIFETECH SCI: VOLUNTARY ANNOUNCEMENT - The first enrollment for confirmatory clinical trials of IBS Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System had been completed in China
Mar 14, 2022 08:00
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.